Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer

Clinical trial NCT06768931 · RECRUITING

Trial details

NCT number: NCT06768931
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Triple Negative Breast Cancer (TNBC)Early Stage Breast Cancer Immunotherapy Probiotic

Start date: 2026-04-01
Primary completion: 2030-01-08
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.